TY  - GEN
AU  - Müller,Nadja
AU  - Michen,Susanne
AU  - Tietze,Stefanie
AU  - Töpfer,Katrin
AU  - Schulte,Alexander
AU  - Lamszus,Katrin
AU  - Schmitz,Marc
AU  - Schackert,Gabriele
AU  - Pastan,Ira
AU  - Temme,Achim
TI  - Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
SN  - 1537-4513
PY  - 2016///0915
KW  - Animals
KW  - Cell Line
KW  - Cell- and Tissue-Based Therapy
KW  - Chemokine CXCL12
KW  - biosynthesis
KW  - Chemotaxis
KW  - genetics
KW  - Cytotoxicity, Immunologic
KW  - Disease Models, Animal
KW  - Ectopic Gene Expression
KW  - ErbB Receptors
KW  - immunology
KW  - Female
KW  - Gene Expression
KW  - Gene Order
KW  - Genetic Therapy
KW  - Genetic Vectors
KW  - administration & dosage
KW  - Glioblastoma
KW  - etiology
KW  - Humans
KW  - Immunotherapy
KW  - Killer Cells, Natural
KW  - Lentivirus
KW  - Mice
KW  - Receptors, Antigen, T-Cell
KW  - Receptors, CXCR4
KW  - Recombinant Fusion Proteins
KW  - Transduction, Genetic
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/CJI.0000000000000082
ER  -